CoChat

The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor‐refractory obsessive‐compulsive disorder: a single‐blind, randomised study

Selvi, Yavuz, Atli, Abdullah, Aydin, Adem, Besiroglu, Lutfullah, Ozdemir, Pinar, Ozdemir, Osman · 2011 · Human Psychopharmacology: Clinical and Experimental
Cited by 64

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

Objective: To investigate the comparative efficacy of aripiprazole and risperidone as augmenting agents in the treatment of obsessive‐compulsive disorder (OCD) patients who did not show a ≥35% decrease in the Yale‐Brown Obsessive‐Compulsive Scale (Y‐BOCS) after 12‐week monotherapy with selective serotonin reuptake inhibitors (SSRIs). Methods: The study consists of two different periods of treatment: a 12‐week prospective period to determine resistance to SSRI treatment and an 8‐week single‐blind addition period for refractory patients only. Ninety patients were randomly assigned to receive one of the SSRI treatments. Sixty‐nine patients (76.6%) completed the 12‐week SSRI monotherapy period. Forty‐one patients (59.4%) were considered refractory and were randomised to receive either risperidone (20 patients, 3 mgr daily) or aripiprazole (21 patients, 15 mgr daily) as augmentation to SSRI treatment. Sixteen patients (76.2%) in the aripiprazole group and 18 patients (84%) in the risperidone group completed the 8‐week treatment period. Results: Eight patients (50%) in aripiprazole and 13 patients (72.2%) in risperidone group met response criteria of Y‐BOCS decrease ≥35% at the end of the study. The risperidone group showed a significant improvement in Y‐BOCS obsession scores compared with aripiprazole. Conclusions: The present findings suggest that risperidone may be more effective than aripiprazole. Copyright © 2011 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hup.1169

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 64

Metadata

Authors
Selvi, Y., Atli, A., Aydin, A., Besiroglu, L., Ozdemir, P., & Ozdemir, O.
Venue
Human Psychopharmacology: Clinical and Experimental
Publisher
Wiley
Published
2011-01
Volume
26
Issue
1
Pages
51-57
ISSN
  • 0885-6222 (ISSN-L)
  • 1099-1077
OpenAlex
W2056932759
Cited by
64
References
10
FWCI
5.29
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.